• Bülent Bakar, Emine Arzu Köse, Sebnem Kupana Ayva, Bahram Sarkarati, Mustafa Omür Kasımcan, and Kamer Kılınç.
• Department of Neurosurgery, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey. bulentbanrs@yahoo.com
• Ulus Travma Acil Cer. 2013 Jul 1;19(4):285-93.

BackgroundThis study was designed to evaluate the possible protective effects of low-dose methotrexate in the spinal cord injury (SCI) in rats.MethodsThirty-seven Wistar albino rats were used in the present study. Except for the animals of the Sham group, all animals were divided into two main groups, which were used in acute and subacute stage investigations. Then, thoracal laminectomy was performed, and except for the Sham group, SCI was induced using a temporary aneurysm clip. After clip compression, the experimental material (methotrexate or methylprednisolone) was administered intraperitoneally, except in the Sham and Control groups. Then, the spinal cords were removed to evaluate the SCI histopathologically and biochemically at the scheduled date.ResultsNeither experimental material was shown to reduce the histopathological grade in either stage of SCI. Low-dose methotrexate was shown to decrease lipid peroxidation levels only in the subacute stage of SCI. However, methylprednisolone and low-dose methotrexate could not decrease or block myeloperoxidase enzyme activation in either stage of SCI.ConclusionLow-dose methotrexate was effective in reducing the lipid peroxidation levels in the subacute stage of SCI, although histopathological evaluation results and myeloperoxidase levels of all groups did not support this finding at either stage.

16 keywords...

hide…